JAZZ Stock Recent News

Some of Wall Street's major stock indexes remain below their all-time highs, which means bargains can still be found. Most online brokerages have done away with commission fees and minimum-deposit requirements, making it easier than ever for retail investors to put their money to work.

Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock?

Data from nine abstracts to be presented, including real-world outcomes of Epidiolex® (cannabidiol) in treatment-resistant focal epilepsies Presentations include data on U.S. caregiver-reported seizure and non-seizure outcomes in patients with tuberous sclerosis complex prescribed Epidiolex  DUBLIN , Dec. 1, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that nine company-sponsored presentations, including five late-breaking abstracts, will be shared at the 2023 American Epilepsy Society (AES) annual meeting, being held December 1-5 in Orlando, Florida. Late-breaking presentations include a post-hoc analysis examining real-world outcomes of Epidiolex® (cannabidiol) in treatment-resistant focal epilepsies within the Expanded Access Program (EAP), as well as a post-hoc analysis of the GWPCARE6 Open-Label Extension (OLE) trial evaluating the effectiveness of Epidiolex as add-on therapy against focal seizures in tuberous sclerosis complex (TSC).

New trial results of  investigational bispecific antibody zanidatamab presented at SABCS in HER2+/HR+ metastatic breast cancer Strong presence at ASH includes 11 presentations spanning Jazz's portfolio, advancing research into difficult-to-treat blood cancers and diseases Real-world data at NACLC reinforce clinical impact of Zepzelca® (lurbinectedin) in small cell lung cancer DUBLIN , Nov. 30, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company and its partners will present two abstracts at the 2023 San Antonio Breast Cancer Symposium (SABCS) from December 5-9; 11 abstracts at the 65th Annual American Society of Hematology (ASH) Annual Meeting from December 9-12; and two abstracts at the International Association for the Study of Lung Cancer (IASLC) 2023 North America Conference on Lung Cancer (NACLC) from December 1-3. New data include updated findings from a Phase 2a trial of the investigational HER2-targeted bispecific antibody zanidatama

Investing in biotech stocks is not for risk-averse investors. However, if you're an investor who is serious about generating outsized gains, it's a sector that you can't overlook.

The Dow, S&P 500, and Nasdaq Composite have teetered between bull and bear markets for much of the past four years. Online brokerages have made it easier than ever to grow your wealth on Wall Street.

Jazz (JAZZ) reports mixed results in third-quarter 2023. However, shares rose 2.5% post the announcement, likely on the back of raised guidance for 2023.

Fleetcor Technologies, Inc. (FLT) Q3 2023 Earnings Conference Call November 8, 2023 5:30 PM ET Company Participants James Eglseder - Head, IR Ronald Clarke - Chairman, President & CEO Thomas Panther - CFO Conference Call Participants Sanjay Sakhrani - KBW Tien-Tsin Huang - JPMorgan Chase & Co. Darrin Peller - Wolfe Research Mihir Bhatia - Bank of America Merrill Lynch Kenneth Suchoski - Autonomous Research Christopher Svensson - Deutsche Bank Ramsey El-Assal - Barclays Bank Robert Napoli - William Blair & Company Trevor Williams - Jefferies Peter Christiansen - Citigroup Operator Good afternoon, ladies and gentlemen, and welcome to the FLEETCOR Technologies, Inc. Third Quarter 2023 Earnings Conference Call. [Operator Instructions].

Although the revenue and EPS for Jazz (JAZZ) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Besides Wall Street's top -and-bottom-line estimates for Jazz (JAZZ), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2023.